Beneficial effect of myocardial angiogenesis on cardiac remodeling process by amlodipine and MCI-154

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 4 45-4, 1999, Pages

  Kumamoto, Hideki ^a   Okamoto, Hiroshi ^a   Watanabe, Masashi ^a   Onozuka, Hisao ^a   Yoneya, Keiji ^a   Nakagawa, Izumi ^a   Chiba, Satoru ^a   Watanabe, Satoshi ^a   Mikami, Taisei ^b   Abe, Kazuhiro ^a   Kitabatake, Akira ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Calcium channel antagonist; Calcium ion; Coronary microvasculature; Dilated cardiomyopathy; Sensitizer

Indexed keywords

4,5 DIHYDRO 6 [4 (4 PYRIDYLAMINO)PHENYL] 3(2H) PYRIDAZINONE; AMLODIPINE; CALCIUM SENSITIZER; MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ECHOCARDIOGRAPHY; GENE EXPRESSION; HAMSTER; HEART DILATATION; HEMODYNAMICS; MALE; MORPHOMETRICS; NONHUMAN; NORTHERN BLOTTING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032962901     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.4.h1117     Document Type: Article

References (30)

1. Al-Wathiqui, M. H., T. M. Shimshak, H. L. Brooks, K. C. Preuss, J. C. Wynsen, G. J. Gross, and D. C. Warltier. Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: action of milrinone, dopamine, ouabain and MCI-154. Pharmacology 36: 217-227, 1988.
2. Ausprunk, D. H., and J. Folkman. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res. 75: 53-65, 1977.
3. Batra, S., and K. Rakusan. Capillary network geometry during postnatal growth in rat hearts. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H635-H640, 1992.
4. Berse, B., L. F. Brown, L. V. De Water, H. F. Dvrak, and D. R. Senger. Vascular permeability factor (vascular endothelial factor) gene expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 3: 211-220, 1992.
5. Conn, G., M. L. Bayne, D. D. Soderman, P. W. Kwok, K. A. Sullivan, T. M. Palisi, D. A. Hope, and K. A. Thomas. Amino acid and cDNA sequence of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 87: 2628-2632, 1990.
6. Factor, S. M., T. Minase, S. Cho, R. Dominitz, and E. M. Sonnenblick. Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation 66: 342-354, 1982.
7. Figgula, H. R., F. Vetterlein, M. Glaubitz, and H. Kreuzer. Inhomogenous capillary flow and its prevention by verapamil and hydralazine in the cardiomyopathic Syrian hamster. Circulation 76: 208-216, 1987.
8. 2+ in intact and skinned trabeculae from control and myopathic human hearts. J. Clin. Invest. 82: 1578-1584, 1988.
9. Haleen, S. J., R. E. Weismarr, R. W. Overhiser, R. F. Bousley, J. A. Keiser, S. R. Rapundalo, and D. G. Tayler. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates. Circ. Res. 68: 1302-1312, 1991.
10. Hashimoto, E., T. Ogita, T. Nakaoka, R. Matsuoka, A. Takao, and Y. Kira. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H1948-H1954, 1994.
11. Ladoux, A., and C. Frelin. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem. Biophys. Res. Commun. 195: 1005-1010, 1993.
12. Li, J., L. F. Brown, M. G. Hibberd, J. D. Grossman, J. P. Morgan, and M. Simons. VEGF, flk-1,and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H1803-H1811, 1996.
13. Li, J., T. Hampton, J. P. Morgan, and M. Simons. Stretch-induced VEGF expession in the heart. J. Clin. Invest. 100:18-24, 1997.
14. 2+ sensitization with a new cardiotonic agent, MCI-154, on diseased human hearts. Cardiovasc. Res. 30: 915-922, 1995.
15. Packer, M., J. R. Carver, R. J. Rodeheffer, R. J. Ivanhoe, R. DiBianco, S. M. Zeldis, G. H. Hendrix, W. J. Bommer, U. Elkayam, M. L. Kukin, G. Mallis, J. A. Sollano, J. Shannon, P. K. Tandon, and D. L. DeMets. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N. Engl. J. Med. 325: 1468-1475, 1991.
16. Packer, M., C. M. O'Connor, J. K. Ghali, M. L. Pressler, P. E. Carson, R. N. Belkin, A. B. Miller, G. W. Neuberg, D. Frid, J. H. Wertheimer, A. B. Cropp, and D. L. DeMets. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N. Engl. J. Med. 335: 1107-1114, 1996.
17. Rouleau, J. L., L. H. S. Chuck, G. Hollosi, O. Kidd, R. E. Sievers, J. Wickman-Coffelt, and W. W. Permley. Verapamil preserves myocardial contractility in the hereditary cardiomyopathy of the Syrian hamster. Circ. Res. 50: 405-412, 1982.
18. Ryu, K. H., N. Tanaka, and J. Ross, Jr. Effects of a sinus node inhibitor on the normal and failing rabbit heart. Basic Res. Cardiol. 91: 131-139, 1996.
19. Sakamoto, A., K. Ono, M. Abe, G. Jasmin, T. Eki, Y. Murakami, T. Masaki, T. Toyo-oka, and F. Hanaoka. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc. Natl. Acad. Sci. USA 94: 13873-13878, 1997.
20. Scalia, G. M., N. L. Greenberg, P. M. MaCarthy, J. D. Thomas, and P. M. Vandervoort. Noninvasive assessment of the ventricular relaxation time constant (τ) in humans by Doppler echocardiography. Circulation 95: 151-155, 1997.
21. Shimada, S., M. Yoshiyama, K. Takeuchi, T. Omura, Y. Takemoto, S. Kim, H. Iwao, and J. Yoshikawa. Long acting calcium antagonist amlodipine prevents left ventricular remodeling after myocardial infarction. Cardiovasc. Res. 37: 618-626, 1998.
22. Sladek, T., J. Sladkova, F. Kolar, F. Papousek, C. Nicholas, B. Korecky, and K. Rakusan. The effect of ATI receptor antagonist on chronic cardiac response to coronary artery ligation in rats. Cardiovasc. Res. 31: 568-576, 1996.
23. 2+ sensitizer, MCI-154, on the myocardial oxygen consumption-cardiac output relation in patients with left ventricular dysfunction after myocardial infarction: comparison with dobutamine and phosphodiesterase inhibitor. Am. Heart J. 133: 283-289, 1997.
24. Tamura, S., T. Yamakado, M. Maeda, and T. Nakano. Effects of MCI-154, a calcium sensitizer, on left ventricular systolic and diastolic function in pacing-induced heart failure in the dog. Circulation 95: 732-739, 1997.
25. Wang, W. Z., A. Matsumori, T. Yamada, T. Shioi, I. Okada, S. Matsui, Y. Sato, H. Suzuki, K. Shiota, and S. Sasayama. Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production. Circulation 95: 245-251, 1997.
26. Watanabe, M., H. Kawaguchi, H. Onozuka, T. Mikami, K. Urasawa, H. Okamoto, S. Watanabe, K. Abe, and A. Kitabatake. Chronic effects of enalapril and amlodipine on cardiac remodeling in cardiomyopathic hamster hearts. J. Cardiovasc. Pharmacol. 32: 248-259, 1998.
27. Waxman, A. M. Blood vessel growth as a problem in morphogenesis: a physical theory. Microvasc. Res. 22: 32-41, 1981.
28. Weisman, H. F. The role of calcium channel abnormalities in Syrian hamster cardiomyopathy. Clin. Immunol. Immunopathol. 68: 170-174, 1993.
29. Xie, Z., M. Gao, and T. Koyama. The capillary of left ventricular tissue of rats subjected to coronary artery occlusion. Cardiovasc. Res. 33: 671-676, 1997.
30. Zhang, X., and T. H. Hintze. Amlodipine releases nitric oxide from canine coronary microvessels. An unexpected mechanism of action of a calcium channel-blocking agent. Circulation 97: 576-580, 1998.